BDNF insufficiency exacerbates ALS progression

Xu and He et al. provide in vivo evidence that BDNF insufficiency exacerbates the symptoms and pathologies in amyotrophic lateral sclerosis (ALS) patients and mouse models, leading to accelerated demise. They develop an agonistic antibody that boosts BDNF signaling and demonstrates therapeutic benefits in multiple models of ALS mice.